RENAISSANCE TECHNOLOGIES LLC

Holdings History for Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

Symbol: MLYS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0.02%	$11,689,009	322,100	+274,700	+580%	$36.29	Q4 2025
30 Sep 2025	0%	-0.01%	$1,797,408	47,400	-129,526	-73%	$37.92	Q3 2025
30 Jun 2025	0%	-0%	$2,393,809	176,926	-374	-0.21%	$13.53	Q2 2025
31 Mar 2025	0%	+0%	$2,815,524	177,300	+57,800		$15.88	Q1 2025
31 Dec 2024	0%	+0%	$1,471,045	119,500	+15,700	+15%	$12.31	Q4 2024
30 Sep 2024	0%	+0%	$1,257,018	103,800	+42,000	+68%	$12.11	Q3 2024
30 Jun 2024	0%	+0%	$723,060	61,800	+30,100	+95%	$11.70	Q2 2024
31 Mar 2024	0%	+0%	$409,000	31,700	+6,200	+24%	$12.90	Q1 2024
31 Dec 2023	0%	-0%	$219,000	25,500	-70,190	-73%	$8.59	Q4 2023
30 Sep 2023	0%	+0%	$910,000	95,690	+95,690	NEW	$9.51	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.